Australian Gene Therapy Biotech Benitec Eyes $70M US IPO
Australia-based Benitec Biopharma Ltd., a clinical-stage biotechnology company developing a gene therapy platform for use on a host of diseases, filed plans with the U.S. Securities and Exchange Commission on Monday...To view the full article, register now.
Already a subscriber? Click here to view full article